1991
DOI: 10.1073/pnas.88.19.8730
|View full text |Cite
|
Sign up to set email alerts
|

Self peptide requirement for class II major histocompatibility complex allorecognition.

Abstract: Using a dinitrophenylated and biotinylated peptide antigen, we have developed an affi chromatography procedure to purify complexes of a given peptide species and a given class U maJor hiptocompatibility complex antigen Boc-e-aminocaproic acids (where Boc is t-butoxycarbonyl) were conjugated to the N terminus of the peptide. In one synthesis, an E-DNP-Lys residue (where DNP is dinitrophenyl) was introduced at the N terminus of the peptide. The peptides were biotinylated in 250 mM NaHCO3/6 M guanidine hydrochlor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
22
0

Year Published

1992
1992
2003
2003

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 22 publications
2
22
0
Order By: Relevance
“…ICS for IFN-␥-producing antigen-specific CD4 ϩ T cells was performed as previously described (6,31,32) with modifications. PBMC (2 million/ml) were incubated with HIV-1 MN gp160 (final concentration, 5 g/ml) or peptide (final concentration, 2 g/ml) in the presence of anti-CD49d (Beckman Coulter, Miami, Fla.) and anti-CD28 (BD Biosciences, San Jose, Calif.) purified MAbs (final concentration, 1.0 g/ml) at 37°C.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…ICS for IFN-␥-producing antigen-specific CD4 ϩ T cells was performed as previously described (6,31,32) with modifications. PBMC (2 million/ml) were incubated with HIV-1 MN gp160 (final concentration, 5 g/ml) or peptide (final concentration, 2 g/ml) in the presence of anti-CD49d (Beckman Coulter, Miami, Fla.) and anti-CD28 (BD Biosciences, San Jose, Calif.) purified MAbs (final concentration, 1.0 g/ml) at 37°C.…”
Section: Methodsmentioning
confidence: 99%
“…Peptide-binding assays were performed as described previously (6,30,31). Specifically, purified human HLA class II molecules (5 to 500 nM) were incubated with various unlabeled peptide inhibitors and 1 to 10 nM 125 I-radiolabeled probe peptide for 48 h in phosphate-buffered saline containing 0.05% Nonidet P-40 in the presence of a protease inhibitor cocktail.…”
Section: Methodsmentioning
confidence: 99%
“…Class II molecules were purified by affinity chromatography, essentially as described previously (20), using the mAb LB3.1 coupled to Sepharose CL-4B beads. Lysates were filtered twice through two precolumns of inactivated Sepharose CL-4B and protein A-Sepharose, and then passed over the anti-DR column.…”
Section: Methodsmentioning
confidence: 99%
“…Two patients discontinued the study at 32 and 40 weeks, thus extended follow-up for these patients is not available. The mean age of the study participants was 31 years (range [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38], and 95% of the patients experienced a symptomatic illness during acute infection. The median duration of infection at study entry was 43 days (range 9-137).…”
Section: Study Populationmentioning
confidence: 99%
“…Most recently, McConnell and coworkers (7) have succeeded in showing, by energy-transfer studies, that two full-length peptides fit into one binding groove, provided that the class II molecule is in its floppy conformation. These findings have interesting implications for alloreactive T-helper cells that are thought to recognize endogenously synthesized cellular peptides associated with an allogeneic MHC (8) or an allo-MHC whose binding site is unoccupied (9). Since there is growing evidence that MHC-derived peptides are also presented to T-helper cells (10)(11)(12), certain combinations of cobinding self-and allopeptides may mimick allo-MHC determinants that are relevant for allorecognition.…”
mentioning
confidence: 99%